Comparison of variant-specific hybridization and single-strand conformational polymorphism methods for detection of mixed human papillomavirus type 16 variant infections

Journal of Clinical Microbiology

Volumn 37, Issue 11, 1999, Pages 3627-3633

  Emeny, Rebecca T ^a   Herron, John R ^a   Xi, Long Fu ^b   Koutsky, Laura A ^b   Kiviat, Nancy B ^b   Wheeler, Cosette M ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOTIDE;

ARTICLE; DIAGNOSTIC ACCURACY; GENE AMPLIFICATION; GENOME; MOLECULAR CLONING; OPEN READING FRAME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SINGLE STRAND CONFORMATION POLYMORPHISM; UTERINE CERVIX TUMOR; WART VIRUS;

EID: 0032836789     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.11.3627-3633.1999     Document Type: Article

References (35)

1. Alvarez-Salas, L. M., S. P. Wilczynski, R. A. Burger, B. J. Monk, and J. A. Dipaolo. 1995. Polymorphism of the HPV16 E6 gene of cervical carcinoma. Int. J. Oncol. 7:261-266.
2. Baker, C. C., W. C. Phelps, V. Lindgren, M. J. Braun, M. A. Gonda, and P. M. Howley. 1987. Structural and transcriptional analysis of human papillomavirus type 16 sequences in cervical carcinoma cell lines. J. Virol. 61: 962-971.
3. Bauer, H. M., C. E. Greer, and M. M. Manos. 1992. Determination of genital HPV infection using consensus PCR, p. 131-152. In C. S. Herrington and J. O. D. McGee (ed.), Diagnostic molecular pathology: a practical approach. Oxford University Press, Oxford, United Kingdom.
4. Bauer, H. M., Y. Ting, and C. E. Greer. 1991. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 265:472-477.
5. Bosch, F. X., M. M. Manos, N. Muñoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, K. V. Shah, and the International Biological Study of Cervical Cancer Study Group. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. J. Natl. Cancer Inst. 87:796-802.
6. Ellis, J. R. M., P. J. Keating, J. Baird, E. F. Hounsell, D. V. Renouf, M. Rowe, D. Hopkins, M. F. Duggan-Keen, J. S. Bartholomew, L. S. Young, and P. L. Stern. 1995. The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nat. Med. 1:464-470.
7. Eluf-Neto, J., M. Booth, N. Muñoz, F. X. Bosch, C. J. L. M. Meijer, and J. M. Walboomers. 1994. Human papillomavirus and invasive cervical cancer in Brazil. Br. J. Cancer 69:114-119.
8. Eriksson, A., J. R. Herron, T. Yamada, and C. M. Wheeler. 1999. Human papillomavirus type 16 variant lineages characterized by nucleotide sequence analysis of the E5 coding segment and the E2 hinge region. J. Gen. Virol. 80:695-600.
9. Greer, C. E., C. M. Wheeler, and M. M. Manos. 1995. PCR amplification from paraffin-embedded tissues: sample preparation and the effects of fixation, p. 99-112. In C. W. Dieffenbach and G. S. Dveksler (ed.), A PCR primer. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
10. Hecht, J. L., A. S. Kadish, G. Jiang, and R. D. Burk. 1995. Genetic characterization of the human papillomavirus (HPV) 18 E2 gene in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer 60:369-376.
11. Heinzel, P. A., C.-Y. Chan, L. Ho, M. O'Connor, P. Balaram, M. S. Campo, K. Fujinaga, N. Kiviat, J. Kuypers, H. Pfister, B. M. Steinberg, S.-K. Tay, L. L. Villa, and H.-U. Bernard. 1995. Variation of human papillomavirus type 6 (HPV-6) and HPV-11 genomes sampled throughout the world. J. Clin. Microbiol. 33:1746-1754.
12. Ho, L., S.-Y. Chan, R. D. Burk, B. C. Das, K. Fujinaga, J. P. Icenogle, T. Kahn, N. Kiviat, W. Lancaster, P. Mavromara-Nazos. V. Labropoulou, S. Mitrani-Rosenbaum, M. Norrild, M. R. Pillai, J. Stoerker, K. Syrjanen, S. Syrjanen, S.-K. Tay, L. L. Villa, C. M. Wheeler, A.-L. Williamson, and H.-U. Bernard. 1993. The genetic drift of human papillomavirus type 16 is a means of reconstructing prehistoric viral spread and the movement of ancient human populations. J. Viral. 67:6413-6423.
13. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 1995. IARC monographs on the evaluation of carcinogenic risks to humans, vol. 64. Human papillomaviruses. International Agency for Research on Cancer, Lyon, France.
14. Icenogle, J. P., K. A. Clancy, and S. Y. Lin. 1995. Sequence variation in the capsid protein genes of human papillomavirus type 16 and type 31. Virology 214:664-669.
15. Koutsky, L., K. K. Holmes, C. W. Critchlow, C. E. Stevens, J. Paavonen, A. M. Beckmann, T. A. DeRouen, D. A. Galloway, D. Vernon, and N. B. Kiviat. 1992. A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection. N. Engl. J. Med. 327: 1272-1278.
16. Londesborough, P., L. Ho, G. Terry, J. Cuzick, C. Wheeler, and A. Singer. 1996. Human papillomavirus genotype as a predictor of persistence and development of high grade lesions in women with minor cervical abnormalities. Int. J. Cancer 69:364-368.
17. Muñoz, N., F. X. Bosch, S. de Sanjosé, L. Tafur, I. Izarzugaza, M. Gili, P. Viladiu, C. Navarro, C. Martos, N. Ascunce, L. C. Gonzalez, J. M. Kaldor, E. Guerrero, A. Lörincz, M. Santamaria, P. Alonso de Ruiz, N. Aristizabal, and K. Shah. 1992. The causal link between human papillomavirus and cervical cancer: a population-based case-control study in Colombia and Spain. Int. J. Cancer 52:743-749.
18. Muñoz, N., L. Crawford, and P. Coursaget. 1995. HPV vaccines and their potential use in the prevention and treatment of cervical neoplasia. Papillomavirus Rep. 654-55.
19. Sanger, F., S. Nicklen, and A. R. Coulson. 1977. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA 74:5463-5467.
20. Schiffman, M. H., H. M. Bauer, R. N. Hoover, A. G. Glass, D. M. Cadell, B. B. Rush, D. R. Scott, M. E. Sherman, R. J. Kurman, S. Wacholer, C. K. Stanton, and M. M. Manos. 1993. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 85:958-964.
21. Seedorf, K., G. Krämmer, M. Dürst, S. Suhai, and W. G. Röwenkamp. 1985. Human papillomavirus type 16 DNA sequence. Virology 145:181-185.
22. Sherman, L. J. A., H. Itzhaki, M. C. Stoppler, D. Koval, and R. Schlegal. 1997. Inhibition of serum- and calcium-induced differentiation of keratinocytes by HPVI6 E6 oncoprotein: role of p53 inactivation. Virology 237: 296-306.
23. Song, Y. S., S. H. Kee, J. W. Kim, N. H. Park, S. B. Kang, W. H. Chang, and H. P. Lee. 1997. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women. Gynecol. Oncol. 66:275-281.
24. Stewart, A.-C. M., A. M. Eriksson, M. M. Manos, N. Muñoz, F. X. Bosch, J. Peto, and C. M. Wheeler. 1996. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J. Virol. 70:3127-3136.
25. Stoeppler, M. C., K. Ching, H. Stoeppler, K. Clancy, R. Schlegel, and J. Icenogle. 1996. Natural variants of the human papillomavirus type 16 E6 protein differ in their abilities to alter keratinocyte differentiation and to induce p53 degradation. J. Virol. 70:6987-6993.
26. Wheeler, C. M., J. R. Herron, J. Peto, and R. Apple. Personal communication.
27. Wheeler, C. M., C. A. Parmenter, W. C. Hunt, T. M. Becker, C. E. Greer, A. Hildesheim, and M. M. Manos. 1993. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico Student Health Center. Sex. Transm. Dis. 20:286-289.
28. Wheeler, C. M., T. Yamada, A. Hildesheim, and S. A. Jenison. 1997. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J. Clin. Microbiol. 35:11-19.
29. Xi, L. F., C. W. Critchlow, C. M. Wheeler, L. A. Koutsky, D. A. Galloway, J. Kuypers, J. P. Hughes, S. E. Hawes, C. Surawicz, G. Goldbaum, K. K. Homes, and N. B. Kiviat. 1998. Risk of anal carcinoma in-situ in relation to human papillomavirus type-16 variants. Cancer Res. 58:3839-3844.
30. Xi, L. F., G. W. Demers, N. B. Kiviat, J. Kuypers, A. M. Beckmann, and D. A. Galloway. 1993. Sequence variation in the noncoding region of human papillomavirus type 16 detected by single-strand conformation polymorphism analysis. J. Infect. Dis. 168:610-617.
31. Xi, L. F., G. W. Demers, L. A. Koutsky, N. B. Kiviat, J. Kuypers, H. Watts, K. K. Holmes, and D. A. Galloway. 1995. Analysis of human papillomavirus type 16 variants indicates establishment of persistent infection. J. Infect. Dis. 172:747-755.
32. Xi, L. F., L. A. Koutsky, D. A. Galloway, J. Kuypers, J. P. Hughes, C. M. Wheeler, K. K. Holmes, and N. B. Kiviat. 1997. Genomic variation of human papillomavirus type 16 and risk for high grade cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 89:796-802.
33. Yamada, T., M. M. Manos, J. Peto, C. E. Greer, N. Muñoz, F. X. Bosch, and C. M. Wheeler. 1997. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 71:2463-2472.
34. Yamada, T, C. M. Wheeler, A. L. Halpern, A.-C. M. Stewart, A. Hildesheim, and S. A. Jenison. 1995. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6, L2, and L1 coding segments. J. Virol. 69:7743-7753.
35. Zehbe, I., E. Wilander, H. Delius, and M. Tommasino. 1998. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 58:829-833.